Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prefrontal Glutamatergic Modulation by N-acetylcysteine and Mindfulness-based Cognitive Therapy for Mild Depression in Youth

NCT07464886 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT07464886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07464886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prefrontal Glutamatergic Modulation by N-acetylcysteine and Mindfulness-based Cognitive Therapy for Mild Depression in Youth
Lead sponsor
University of Cincinnati
Phase
Phase 3
Overall status
Recruiting
Start date
February 26, 2026
Completion date
December 31, 2030
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild depression